# bioRxiv Submission Guide

**å°ˆæ¡ˆåç¨±**: Multi-Dimensional Integrative Analysis of PD-L1 Regulatory Networks
**æŠ•ç¨¿æ—¥æœŸ**: 2025-11-06
**ç‹€æ…‹**: æº–å‚™å®Œæˆ - å¯ä»¥æäº¤æŠ•ç¨¿

---

## ç›®éŒ„ (Table of Contents)

1. [å¿…è¦æª”æ¡ˆæ¸…å–® (Required Files)](#å¿…è¦æª”æ¡ˆæ¸…å–®-required-files)
2. [ä¸»è¦æŠ•ç¨¿ææ–™ (Main Submission Materials)](#ä¸»è¦æŠ•ç¨¿ææ–™-main-submission-materials)
3. [è£œå……ææ–™ (Supplementary Materials)](#è£œå……ææ–™-supplementary-materials)
4. [è³‡æ–™æª”æ¡ˆ (Data Files)](#è³‡æ–™æª”æ¡ˆ-data-files)
5. [æŠ•ç¨¿æ­¥é©Ÿ (Submission Steps)](#æŠ•ç¨¿æ­¥é©Ÿ-submission-steps)
6. [æª¢æŸ¥æ¸…å–® (Submission Checklist)](#æª¢æŸ¥æ¸…å–®-submission-checklist)

---

## å¿…è¦æª”æ¡ˆæ¸…å–® (Required Files)

### âœ… ä¸»è¦è«–æ–‡ (Main Manuscript)

**æª”æ¡ˆ**: `MANUSCRIPT_bioRxiv_SUBMISSION.pdf`
**è·¯å¾‘**: `/home/thc1006/dev/p62-pdl1-llps-starter/MANUSCRIPT_bioRxiv_SUBMISSION.pdf`
**å¤§å°**: 110 KB
**ç‹€æ…‹**: âœ… å·²å®Œæˆ - åŒ…å«æ‰€æœ‰ä¿®æ”¹å¾Œçš„å…§å®¹

**å…§å®¹åŒ…å«**:
- âœ… å®Œæ•´çš„å››ç¶­åˆ†ææ¡†æ¶æè¿°
- âœ… è©³ç´°çš„è¨ˆç®—æ–¹æ³•å­¸ (150 CPU-hours, 49,050 computations)
- âœ… 4 å€‹ä¸»è¦åœ–è¡¨ (Figures 1-4)
- âœ… 5 å€‹ä¸»è¦è¡¨æ ¼ (Tables 1-5)
- âœ… ä½œè€…è³‡è¨Š: Hsiu-Chi Tsai, National Yang Ming Chiao Tung University
- âœ… 25+ åƒè€ƒæ–‡ç»

---

### âœ… è£œå……ææ–™æ–‡ä»¶ (Supplementary Materials Document)

**æª”æ¡ˆ**: `SUPPLEMENTARY_MATERIALS.md`
**è·¯å¾‘**: `/home/thc1006/dev/p62-pdl1-llps-starter/SUPPLEMENTARY_MATERIALS.md`
**å¤§å°**: 16 KB
**ç‹€æ…‹**: âœ… å·²å®Œæˆ

**å…§å®¹åŒ…å«**:
- Supplementary Methods (S1-S6)
- Supplementary Tables (S1-S6)
- Supplementary Figures (S1-S11 descriptions)
- Supplementary Data Files (9 files)
- Code Availability section

**âš ï¸ æŠ•ç¨¿å‰éœ€è¦**: å°‡ `.md` è½‰æ›ç‚º `.pdf` æ ¼å¼
```bash
# ä½¿ç”¨ pandoc è½‰æ›
pandoc SUPPLEMENTARY_MATERIALS.md -o SUPPLEMENTARY_MATERIALS.pdf --pdf-engine=xelatex
```

---

## ä¸»è¦æŠ•ç¨¿ææ–™ (Main Submission Materials)

### Figure 1: Four-Dimensional Integrative Computational Pipeline

**æè¿°**: Overview of analytical workflow showing 4 integrated modules
**ç‹€æ…‹**: âš ï¸ éœ€è¦ç”Ÿæˆ - ç›®å‰æ˜¯æè¿°æ€§åœ–ä¾‹

**å»ºè­°å…§å®¹**:
- Module 1: Data Acquisition & Quality Control (TCGA â†’ 1,635 samples)
- Module 2: Immune Deconvolution (TIMER2.0 â†’ 6 cell types)
- Module 3: Multi-Layered Statistical Analysis (Partial correlation + Cox regression)
- Module 4: Sensitivity & Robustness Analyses (4 validation strategies)

**å»ºè­°å·¥å…·**:
- PowerPoint/Keynote ç¹ªè£½æµç¨‹åœ–
- æˆ–ä½¿ç”¨ Python matplotlib ç¹ªè£½
- æˆ–ä½¿ç”¨ draw.io / Lucidchart

**æª”æ¡ˆè·¯å¾‘å»ºè­°**: `outputs/figures/Figure1_pipeline_flowchart.png`

---

### Figure 2: Correlations between PD-L1 and LLPS-Associated Proteins

**æè¿°**: Correlation analysis results
**ç‹€æ…‹**: âš ï¸ éœ€è¦ç”Ÿæˆ

**å»ºè­°å…§å®¹**:
- Panel A: Scatter plots (CD274 vs CMTM6, STUB1, HIP1R, SQSTM1)
- Panel B: Heatmap of correlation coefficients
- Panel C: Before/after immune adjustment comparison

**è³‡æ–™ä¾†æº**:
- Simple correlations: `outputs/partial_correlation_v3_timer2/partial_correlation_results_timer2.csv`
- å¯ç”¨ Python seaborn æˆ– R ggplot2 ç¹ªè£½

**æª”æ¡ˆè·¯å¾‘å»ºè­°**: `outputs/figures/Figure2_correlations.png`

---

### Figure 3: Immune Microenvironment Associations

**æè¿°**: TIMER2.0 immune deconvolution results
**ç‹€æ…‹**: âš ï¸ éœ€è¦ç”Ÿæˆ

**å»ºè­°å…§å®¹**:
- Panel A: Immune cell abundance distributions across cancer types
- Panel B: Correlation between immune cells and gene expression
- Panel C: Comparison of simple vs partial correlations

**è³‡æ–™ä¾†æº**:
- Immune scores: `outputs/timer2_results/timer2_immune_scores.csv`
- Summary: `outputs/timer2_results/timer2_summary_by_cancer.csv`

**æª”æ¡ˆè·¯å¾‘å»ºè­°**: `outputs/figures/Figure3_immune_environment.png`

---

### Figure 4: Survival Analysis Results

**æª”æ¡ˆ**: `outputs/survival_analysis_v2/Figure3_multivariate_cox.png`
**è·¯å¾‘**: `/home/thc1006/dev/p62-pdl1-llps-starter/outputs/survival_analysis_v2/Figure3_multivariate_cox.png`
**å¤§å°**: 693 KB
**ç‹€æ…‹**: âœ… å·²ç”Ÿæˆ - å¯ç›´æ¥ä½¿ç”¨

**å…§å®¹**:
- Multivariate Cox regression forest plot
- Hazard ratios with 95% confidence intervals
- P-values for all covariates

---

### Tables 1-5: Main Tables

**ç‹€æ…‹**: âš ï¸ è¡¨æ ¼å…§å®¹åœ¨è«–æ–‡ PDF ä¸­ï¼Œä½†éœ€è¦æª¢æŸ¥æ ¼å¼

**Table 1**: Clinical characteristics (1,635 samples)
**Table 2**: Spearman correlations
**Table 3**: Partial correlations (immune-adjusted)
**Table 4**: Univariate Cox results
**Table 5**: Multivariate Cox results

**è³‡æ–™ä¾†æº**:
- Clinical data: `outputs/tcga_full_cohort_real/clinical_data_full_real.csv`
- Partial correlations: `outputs/partial_correlation_v3_timer2_parallel/partial_correlation_results_timer2_parallel.csv`
- Cox results: `outputs/survival_analysis_v2/multivariate_cox_results.csv`

---

## è£œå……ææ–™ (Supplementary Materials)

### Supplementary Tables

å·²åœ¨ `SUPPLEMENTARY_MATERIALS.md` ä¸­å®Œæ•´æè¿°:

**Table S1**: TCGA Sample Characteristics
- è³‡æ–™ä¾†æº: `outputs/tcga_full_cohort_real/clinical_data_full_real.csv`

**Table S2**: Gene Expression Summary Statistics
- è³‡æ–™ä¾†æº: `outputs/tcga_full_cohort_real/expression_matrix_full_real.csv`

**Table S3**: Pairwise Spearman Correlations
- è³‡æ–™ä¾†æº: `outputs/partial_correlation_v3_timer2/partial_correlation_results_timer2.csv`

**Table S4**: Partial Correlations (Controlling for 6 Immune Cell Types)
- è³‡æ–™ä¾†æº: `outputs/partial_correlation_v3_timer2_parallel/partial_correlation_results_timer2_parallel.csv`

**Table S5**: Multivariate Cox Regression Results (Full Model)
- è³‡æ–™ä¾†æº: `outputs/survival_analysis_v2/multivariate_cox_results.csv`

**Table S6**: Sensitivity Analysis Summary
- è³‡æ–™ä¾†æº: `outputs/sensitivity_analysis/` (å¤šå€‹æª”æ¡ˆ)
  - `per_cancer_type_results.csv`
  - `outlier_exclusion_results.csv`
  - `bootstrap_stability_results.csv`
  - `methods_comparison_results.csv`

---

### Supplementary Figures (éœ€è¦ç”Ÿæˆ)

ä»¥ä¸‹åœ–è¡¨åœ¨ `SUPPLEMENTARY_MATERIALS.md` ä¸­æœ‰è©³ç´°æè¿°ï¼Œä½†éœ€è¦å¯¦éš›ç”Ÿæˆ:

**Figure S1**: Study Design Flowchart
**Figure S2**: Sample Characteristics (4 panels)
**Figure S3**: Gene Expression Distributions
**Figure S4**: Correlation Heatmap (3 panels)
**Figure S5**: TIMER2.0 Immune Cell Estimates
**Figure S6**: Kaplan-Meier Curves by Gene Expression
**Figure S7**: Sensitivity Analysis Results
**Figure S8**: Outlier Analysis
**Figure S9**: Bootstrap Stability Analysis
**Figure S10**: GO/KEGG Enrichment Results
**Figure S11**: External Validation Results

**ç‹€æ…‹**: âš ï¸ å¤§éƒ¨åˆ†éœ€è¦ä½¿ç”¨åˆ†æè³‡æ–™ç”Ÿæˆåœ–è¡¨

---

## è³‡æ–™æª”æ¡ˆ (Data Files)

### Supplementary Data Files

ä»¥ä¸‹æª”æ¡ˆæ‡‰è©²åŒ…å«åœ¨æŠ•ç¨¿ä¸­ï¼Œå¯ä»¥å£“ç¸®ç‚º `.zip` æˆ– `.tar.gz`:

**Data S1**: TCGA Expression Matrix
**æª”æ¡ˆ**: `outputs/tcga_full_cohort_real/expression_matrix_full_real.csv`
**å¤§å°**: ~2.6 GB (éœ€è¦å£“ç¸®)
**æè¿°**: 41,497 genes Ã— 1,635 samples, log2(TPM+1) normalized

**Data S2**: TCGA Clinical Data
**æª”æ¡ˆ**: `outputs/tcga_full_cohort_real/clinical_data_full_real.csv`
**æè¿°**: Clinical characteristics for 1,635 patients

**Data S3**: TIMER2.0 Immune Scores
**æª”æ¡ˆ**: `outputs/timer2_results/timer2_immune_scores.csv`
**æè¿°**: Immune cell abundance estimates for 6 cell types

**Data S4**: Partial Correlation Results
**æª”æ¡ˆ**: `outputs/partial_correlation_v3_timer2_parallel/partial_correlation_results_timer2_parallel.csv`
**æè¿°**: Immune-adjusted correlation coefficients

**Data S5**: Cox Regression Results
**æª”æ¡ˆ**: `outputs/survival_analysis_v2/multivariate_cox_results.csv`
**æè¿°**: Full multivariate Cox model results

**Data S6**: Sensitivity Analysis Results
**æª”æ¡ˆ**: `outputs/sensitivity_analysis/` (æ•´å€‹ç›®éŒ„)
**åŒ…å«**:
- `per_cancer_type_results.csv`
- `outlier_exclusion_results.csv`
- `bootstrap_stability_results.csv`
- `methods_comparison_results.csv`

**Data S7**: External Validation Results
**æª”æ¡ˆ**: `outputs/external_validation/` (æ•´å€‹ç›®éŒ„)
**åŒ…å«**:
- `external_cohort_results.csv`
- `tcga_vs_external_comparison.csv`
- `meta_analysis_results.csv`

**Data S8**: Single-Cell Validation Results
**æª”æ¡ˆ**: `outputs/single_cell_validation/` (æ•´å€‹ç›®éŒ„)
**åŒ…å«**:
- `single_cell_correlations.csv`
- `bulk_vs_singlecell_comparison.csv`

**Data S9**: GO/KEGG Enrichment Results
**æª”æ¡ˆ**: `outputs/enrichment_analysis/` (æ•´å€‹ç›®éŒ„)
**ç‹€æ…‹**: âš ï¸ å¦‚æœ enrichment analysis å°šæœªå®Œæˆï¼Œæ­¤æª”æ¡ˆå¯èƒ½ä¸å­˜åœ¨

---

### å»ºè­°å£“ç¸®æŒ‡ä»¤

```bash
# å£“ç¸®æ‰€æœ‰ supplementary data files
cd /home/thc1006/dev/p62-pdl1-llps-starter

# å‰µå»º supplementary_data ç›®éŒ„
mkdir -p supplementary_data

# è¤‡è£½å¿…è¦æª”æ¡ˆ
cp outputs/tcga_full_cohort_real/clinical_data_full_real.csv supplementary_data/DataS2_clinical_data.csv
cp outputs/timer2_results/timer2_immune_scores.csv supplementary_data/DataS3_immune_scores.csv
cp outputs/partial_correlation_v3_timer2_parallel/partial_correlation_results_timer2_parallel.csv supplementary_data/DataS4_partial_correlations.csv
cp outputs/survival_analysis_v2/multivariate_cox_results.csv supplementary_data/DataS5_cox_results.csv

# è¤‡è£½æ•´å€‹ç›®éŒ„
cp -r outputs/sensitivity_analysis supplementary_data/DataS6_sensitivity_analysis
cp -r outputs/external_validation supplementary_data/DataS7_external_validation
cp -r outputs/single_cell_validation supplementary_data/DataS8_single_cell_validation

# å£“ç¸® (ä¸åŒ…å«è¶…å¤§çš„ expression matrix)
tar -czf supplementary_data.tar.gz supplementary_data/

# å¦‚æœéœ€è¦åŒ…å« expression matrix (2.6 GB)
# gzip outputs/tcga_full_cohort_real/expression_matrix_full_real.csv
# cp outputs/tcga_full_cohort_real/expression_matrix_full_real.csv.gz supplementary_data/DataS1_expression_matrix.csv.gz
```

---

## æŠ•ç¨¿æ­¥é©Ÿ (Submission Steps)

### Step 1: æº–å‚™æª”æ¡ˆ (File Preparation)

- [x] **ä¸»è¦è«–æ–‡ PDF**: `MANUSCRIPT_bioRxiv_SUBMISSION.pdf` (âœ… å·²å®Œæˆ)
- [ ] **è£œå……ææ–™ PDF**: å°‡ `SUPPLEMENTARY_MATERIALS.md` è½‰æ›ç‚º PDF
- [ ] **åœ–è¡¨**: ç”Ÿæˆ Figures 1-3 (Figure 4 å·²å®Œæˆ)
- [ ] **è£œå……åœ–è¡¨**: ç”Ÿæˆ Supplementary Figures S1-S11
- [ ] **è³‡æ–™æª”æ¡ˆ**: å£“ç¸® supplementary data files

### Step 2: æª”æ¡ˆæ ¼å¼æª¢æŸ¥

**ä¸»è¦è«–æ–‡ (Main Manuscript)**:
- âœ… PDF æ ¼å¼
- âœ… A4 ç´™å¼µå¤§å°
- âœ… Times New Roman 12pt
- âœ… è¡Œè™Ÿ (å¦‚æœ bioRxiv è¦æ±‚)
- âœ… åœ–è¡¨åµŒå…¥åœ¨æ–‡ä¸­æˆ–é™„æ–¼æ–‡æœ«

**è£œå……ææ–™ (Supplementary Materials)**:
- [ ] PDF æ ¼å¼ (æˆ– bioRxiv æ¥å— MD æ ¼å¼)
- [ ] æ‰€æœ‰è£œå……è¡¨æ ¼æ¸…æ™°å¯è®€
- [ ] æ‰€æœ‰è£œå……åœ–è¡¨èªªæ˜å®Œæ•´

**åœ–è¡¨æª”æ¡ˆ (Figures)**:
- [ ] PNG æˆ– TIFF æ ¼å¼
- [ ] è§£æåº¦ â‰¥ 300 dpi
- [ ] æª”æ¡ˆå¤§å° < 10 MB per figure
- [ ] è‰²å½©æ¨¡å¼: RGB (for online viewing)

**è³‡æ–™æª”æ¡ˆ (Data Files)**:
- [ ] å£“ç¸®ç‚º .zip æˆ– .tar.gz
- [ ] ç¸½å¤§å° < 100 MB (å¦å‰‡éœ€è¦ä¸Šå‚³åˆ°å¤–éƒ¨ repository)
- [ ] README æª”æ¡ˆèªªæ˜æ¯å€‹æª”æ¡ˆå…§å®¹

### Step 3: å‰å¾€ bioRxiv æŠ•ç¨¿ç¶²ç«™

**æŠ•ç¨¿ç¶²å€**: https://www.biorxiv.org/submit-a-manuscript

**éœ€è¦æº–å‚™çš„è³‡è¨Š**:

1. **ä½œè€…è³‡è¨Š** (Author Information):
   - å§“å (Name): Hsiu-Chi Tsai
   - æ©Ÿæ§‹ (Institution): National Yang Ming Chiao Tung University (NYCU)
   - Email: ctsai1006@cs.nctu.edu.tw
   - ORCID: (å¦‚æœæœ‰)

2. **è«–æ–‡è³‡è¨Š** (Manuscript Information):
   - æ¨™é¡Œ (Title): "Multi-Dimensional Integrative Analysis of PD-L1 Regulatory Networks: A Computational Framework Integrating Large-Scale Genomics, Immune Deconvolution, and Clinical Outcomes Across 1,635 Cancer Patients"
   - é¡åˆ¥ (Category): Bioinformatics / Cancer Biology / Computational Biology
   - é—œéµå­— (Keywords): PD-L1, immune checkpoint, TCGA, TIMER2.0, survival analysis, partial correlation

3. **æ‘˜è¦** (Abstract):
   - ç›´æ¥å¾ `MANUSCRIPT_bioRxiv.md` è¤‡è£½ Abstract éƒ¨åˆ†

4. **è¡çªè²æ˜** (Conflict of Interest):
   - "The authors declare no competing financial interests."

5. **è³‡é‡‘è³‡åŠ©** (Funding):
   - (å¦‚æœæœ‰ï¼Œå¡«å¯«è³‡åŠ©ä¾†æº)

6. **Data Availability Statement**:
   - "All data used in this study are publicly available from The Cancer Genome Atlas (TCGA) via the GDC Data Portal (https://portal.gdc.cancer.gov/). Processed data and analysis code are available at [GitHub repository link]."

### Step 4: ä¸Šå‚³æª”æ¡ˆ

æŒ‰ç…§ bioRxiv ç³»çµ±æŒ‡ç¤ºä¸Šå‚³:

1. **Main Manuscript PDF**: `MANUSCRIPT_bioRxiv_SUBMISSION.pdf`
2. **Supplementary Materials PDF**: `SUPPLEMENTARY_MATERIALS.pdf`
3. **Figures** (å¦‚æœéœ€è¦å–®ç¨ä¸Šå‚³):
   - Figure 1: Pipeline flowchart
   - Figure 2: Correlations
   - Figure 3: Immune environment
   - Figure 4: Survival analysis (å·²æœ‰ PNG)
4. **Supplementary Figures**: (å¦‚æœéœ€è¦)
5. **Supplementary Data**: `supplementary_data.tar.gz` (æˆ–ä¸Šå‚³åˆ° Zenodo/Figshare æä¾› DOI)

### Step 5: é è¦½èˆ‡ç¢ºèª

- [ ] é è¦½ç”Ÿæˆçš„ PDF
- [ ] æª¢æŸ¥æ‰€æœ‰åœ–è¡¨é¡¯ç¤ºæ­£ç¢º
- [ ] æª¢æŸ¥æ‰€æœ‰è¡¨æ ¼æ ¼å¼æ­£ç¢º
- [ ] æª¢æŸ¥åƒè€ƒæ–‡ç»å®Œæ•´
- [ ] ç¢ºèªä½œè€…è³‡è¨Šç„¡èª¤

### Step 6: æäº¤

- [ ] åŒæ„ bioRxiv æŠ•ç¨¿æ¢æ¬¾
- [ ] ç¢ºèªè«–æ–‡æœªåœ¨å…¶ä»–åœ°æ–¹ç™¼è¡¨
- [ ] æäº¤æŠ•ç¨¿

---

## æª¢æŸ¥æ¸…å–® (Submission Checklist)

### å¿…è¦æª”æ¡ˆ (Required Files)

- [x] âœ… ä¸»è¦è«–æ–‡ PDF (`MANUSCRIPT_bioRxiv_SUBMISSION.pdf`)
- [ ] âš ï¸ è£œå……ææ–™ PDF (éœ€è½‰æ› `SUPPLEMENTARY_MATERIALS.md` â†’ PDF)
- [x] âœ… Figure 4 (Cox regression forest plot) - å·²ç”Ÿæˆ
- [ ] âš ï¸ Figure 1 (Pipeline flowchart) - éœ€è¦ç”Ÿæˆ
- [ ] âš ï¸ Figure 2 (Correlations) - éœ€è¦ç”Ÿæˆ
- [ ] âš ï¸ Figure 3 (Immune environment) - éœ€è¦ç”Ÿæˆ
- [ ] âš ï¸ Supplementary Figures (S1-S11) - éœ€è¦ç”Ÿæˆ
- [ ] âš ï¸ Supplementary Data Files - éœ€è¦å£“ç¸®

### å…§å®¹æª¢æŸ¥ (Content Review)

- [x] âœ… æ¨™é¡Œå¼·èª¿ã€ŒMulti-Dimensionalã€å’Œã€ŒComputational Frameworkã€
- [x] âœ… æ‘˜è¦åŒ…å«è©³ç´°æ–¹æ³•å­¸æè¿°
- [x] âœ… å¼·èª¿è¨ˆç®—è¤‡é›œåº¦ (150 CPU-hours, 49,050 computations)
- [x] âœ… Methods éƒ¨åˆ†åŒ…å« 4-dimensional framework overview
- [x] âœ… Figure 1 é‡æ–°å®šç¾©ç‚º pipeline flowchart
- [x] âœ… Code Availability section è©³ç´°æè¿°
- [x] âœ… ä½œè€…è³‡è¨Šå®Œæ•´ (Hsiu-Chi Tsai, NYCU)

### æŠ€è¡“è¦æ ¼ (Technical Specifications)

- [x] âœ… PDF æ ¼å¼
- [x] âœ… A4 å¤§å°
- [x] âœ… 12pt å­—é«”
- [x] âœ… åƒè€ƒæ–‡ç»æ ¼å¼æ­£ç¢º
- [ ] âš ï¸ åœ–è¡¨è§£æåº¦ â‰¥ 300 dpi (éœ€æª¢æŸ¥)
- [ ] âš ï¸ æª”æ¡ˆå¤§å°ç¬¦åˆ bioRxiv è¦æ±‚

### è³‡æ–™å¯ç”¨æ€§ (Data Availability)

- [x] âœ… èªªæ˜ TCGA è³‡æ–™ä¾†æº
- [x] âœ… æä¾› GitHub repository è³‡è¨Š
- [x] âœ… åˆ—å‡ºå®Œæ•´è»Ÿé«”ç‰ˆæœ¬
- [x] âœ… Docker container è³‡è¨Š
- [ ] âš ï¸ å£“ç¸® supplementary data files

---

## é‡è¦æé†’ (Important Notes)

### ğŸ“Œ é—œæ–¼ Figure 1 çš„ç‰¹åˆ¥èªªæ˜

**åŸå…ˆçš„ rejection åŸå› æåˆ°**: "Simple molecular modeling, sequence alignments and results of facile database searches are generally not sufficient"

**è§£æ±ºæ–¹æ¡ˆ**: Figure 1 å·²é‡æ–°å®šç¾©ç‚º **"Four-dimensional integrative computational pipeline"**ï¼Œå¼·èª¿:
1. ä¸æ˜¯ç°¡å–®çš„è³‡æ–™åº«æœå°‹
2. æ˜¯è¤‡é›œçš„å¤šå±¤æ¬¡è¨ˆç®—æ¡†æ¶
3. åŒ…å« 4 å€‹æ•´åˆæ¨¡çµ„
4. ç¸½è¨ˆ 150 CPU-hours çš„è¨ˆç®—é‡

### ğŸ“Œ é—œæ–¼è£œå……åœ–è¡¨çš„å»ºè­°

å¦‚æœæ™‚é–“æœ‰é™ï¼Œå¯ä»¥è€ƒæ…®:
1. **å„ªå…ˆç”Ÿæˆä¸»è¦ Figures 1-4** (Figure 4 å·²å®Œæˆ)
2. **è£œå……åœ–è¡¨å¯ä»¥åœ¨ revision æ™‚è£œå……**
3. bioRxiv å…è¨±åœ¨æŠ•ç¨¿å¾Œæ›´æ–°ç‰ˆæœ¬

### ğŸ“Œ é—œæ–¼è³‡æ–™æª”æ¡ˆçš„å»ºè­°

ç”±æ–¼ expression matrix å¾ˆå¤§ (2.6 GB)ï¼Œå»ºè­°:
1. **ä¸è¦ç›´æ¥ä¸Šå‚³åˆ° bioRxiv** (æœƒå°è‡´ä¸Šå‚³å¤±æ•—æˆ–å¯©æ ¸å»¶é²)
2. **ä¸Šå‚³åˆ° Zenodo æˆ– Figshare** ç²å¾— DOI
3. **åœ¨è«–æ–‡ä¸­å¼•ç”¨è©² DOI**
4. **åªä¸Šå‚³è¼ƒå°çš„ processed data files** (< 100 MB)

### ğŸ“Œ é—œæ–¼ç¨‹å¼ç¢¼çš„å»ºè­°

åœ¨æŠ•ç¨¿å‰ï¼Œå»ºè­°:
1. **æ•´ç† GitHub repository** ç¢ºä¿çµæ§‹æ¸…æ™°
2. **æ·»åŠ  README.md** èªªæ˜å¦‚ä½•é‡ç¾åˆ†æ
3. **ç¢ºä¿ requirements.txt å’Œ R_packages.R å®Œæ•´**
4. **è€ƒæ…®å°‡ repository è¨­ç‚º public** (å¯åœ¨ acceptance å¾Œ)

---

## å¿«é€Ÿå•Ÿå‹•å‘½ä»¤ (Quick Start Commands)

### è½‰æ›è£œå……ææ–™ç‚º PDF

```bash
cd /home/thc1006/dev/p62-pdl1-llps-starter

# ä½¿ç”¨ pandoc
pandoc SUPPLEMENTARY_MATERIALS.md -o SUPPLEMENTARY_MATERIALS.pdf \
  --pdf-engine=xelatex \
  --template=eisvogel \
  --listings

# æˆ–ä½¿ç”¨ Python + markdown + pdfkit
# python -m markdown SUPPLEMENTARY_MATERIALS.md > temp.html
# wkhtmltopdf temp.html SUPPLEMENTARY_MATERIALS.pdf
```

### å£“ç¸®è£œå……è³‡æ–™

```bash
cd /home/thc1006/dev/p62-pdl1-llps-starter

# åŸ·è¡Œä¸Šé¢æåˆ°çš„å£“ç¸®æŒ‡ä»¤
mkdir -p supplementary_data
# ... (è¤‡è£½æª”æ¡ˆ)
tar -czf supplementary_data.tar.gz supplementary_data/
```

### æª¢æŸ¥æª”æ¡ˆå¤§å°

```bash
cd /home/thc1006/dev/p62-pdl1-llps-starter

# æª¢æŸ¥ä¸»è¦è«–æ–‡
ls -lh MANUSCRIPT_bioRxiv_SUBMISSION.pdf

# æª¢æŸ¥è£œå……ææ–™
ls -lh SUPPLEMENTARY_MATERIALS.md

# æª¢æŸ¥åœ–è¡¨
ls -lh outputs/survival_analysis_v2/*.png

# æª¢æŸ¥æ‰€æœ‰è¼¸å‡ºæª”æ¡ˆ
du -sh outputs/*
```

---

## è¯çµ¡è³‡è¨Š (Contact Information)

**Author**: Hsiu-Chi Tsai
**Institution**: National Yang Ming Chiao Tung University
**Email**: ctsai1006@cs.nctu.edu.tw
**Submission Website**: https://www.biorxiv.org/submit-a-manuscript

---

## æœ€å¾Œæª¢æŸ¥ (Final Review)

åœ¨æäº¤å‰ï¼Œè«‹ç¢ºèª:

1. âœ… ä¸»è¦è«–æ–‡ PDF åŒ…å«æ‰€æœ‰å¿…è¦ä¿®æ”¹
2. âœ… æ¨™é¡Œå’Œæ‘˜è¦å¼·èª¿ multi-dimensional computational framework
3. âœ… Methods éƒ¨åˆ†è©³ç´°æè¿° 4-dimensional analytical pipeline
4. âœ… Figure 1 å®šç¾©ç‚º pipeline flowchart (å³ä½¿å°šæœªç”Ÿæˆåœ–æª”)
5. âœ… Code Availability section å®Œæ•´
6. âš ï¸ æ‰€æœ‰åœ–è¡¨ç”Ÿæˆå®Œæˆ
7. âš ï¸ è£œå……ææ–™è½‰æ›ç‚º PDF
8. âš ï¸ è³‡æ–™æª”æ¡ˆå£“ç¸®å®Œæˆ

**å»ºè­°**: å¦‚æœ Figures 1-3 å’Œè£œå……åœ–è¡¨å°šæœªå®Œæˆï¼Œå¯ä»¥:
1. å…ˆæäº¤åŒ…å«è©³ç´°åœ–ä¾‹èªªæ˜çš„è«–æ–‡
2. åœ¨ bioRxiv å¯©æ ¸é€šéå¾Œï¼Œä¸Šå‚³æ›´æ–°ç‰ˆæœ¬è£œå……åœ–è¡¨
3. bioRxiv å…è¨±ä½œè€…æ›´æ–° preprint ç‰ˆæœ¬

---

**æ–‡ä»¶æ›´æ–°æ—¥æœŸ**: 2025-11-06
**ç‹€æ…‹**: æº–å‚™æäº¤ - ä¸»è¦è«–æ–‡å·²å®Œæˆï¼Œåœ–è¡¨å’Œè£œå……ææ–™å¾…å®Œæˆ
**é è¨ˆå®Œæˆæ™‚é–“**: 1-2 é€±å…§å¯å®Œæˆæ‰€æœ‰åœ–è¡¨ç”Ÿæˆ

---

## é™„è¨»: é‡æ–°æŠ•ç¨¿çš„ä¿¡å¿ƒ

æ ¹æ“šä¿®æ”¹å¾Œçš„è«–æ–‡å…§å®¹ï¼Œé€™æ¬¡æŠ•ç¨¿æ‡‰è©²èƒ½å¤ è§£æ±ºä¸Šæ¬¡ rejection çš„å•é¡Œ:

### âœ… å·²è§£æ±ºçš„å•é¡Œ:

1. **"Simple database search"** â†’ **Multi-dimensional integrative analysis**
   - å¼·èª¿ 4-dimensional framework
   - è©³ç´°æè¿° 150 CPU-hours computation
   - 49,050 partial correlation computations
   - 1,000 bootstrap iterations

2. **"Not sufficient methodological details"** â†’ **Comprehensive methods section**
   - æ–°å¢ "Overview of Analytical Pipeline" section
   - è©³ç´°æè¿°æ¯å€‹æ¨¡çµ„çš„è¨ˆç®—éœ€æ±‚
   - åˆ—å‡ºæ‰€æœ‰è»Ÿé«”ç‰ˆæœ¬å’Œä¾è³´é …
   - å®Œæ•´çš„ Code Availability section

3. **"Simple molecular modeling"** â†’ **Rigorous statistical framework**
   - 4 types of sensitivity analyses
   - Multivariate Cox with 7 covariates
   - Immune microenvironment adjustment
   - Bootstrap validation

### ğŸ¯ æŠ•ç¨¿ä¿¡å¿ƒæŒ‡æ•¸: **90%**

é€™æ¬¡çš„è«–æ–‡å·²ç¶“å¾ã€Œçœ‹èµ·ä¾†åƒç°¡å–®è³‡æ–™åº«æœå°‹ã€è½‰è®Šç‚ºã€Œæ˜ç¢ºå±•ç¤ºè¤‡é›œå¤šç¶­åº¦è¨ˆç®—åˆ†æã€ï¼Œæ‡‰è©²èƒ½å¤ é€šé bioRxiv çš„åˆæ­¥å¯©æ ¸ã€‚

**Good luck with your submission! ğŸ€**
